EU Commission
European Commission reports show misuse of divisionals can in itself contravene EU law
By Mikkel Roed Trier | Posted on January 28, 2025
In November last year, I was interviewed about the European Commission’s €462.6 million fine against pharmaceutical giant Teva and what it could mean for European patent practices. In short, the European Commission fined Teva for artificially extending patent protection by pursuing divisionals and spreading misleading information about a competing product to hinder its market entry...
A new exemption from supplementary protection certificates (SPC) in the EU
By Louise Jonshammar | Posted on May 30, 2018
Some thoughts on the EU Commission proposal for manufacturing waivers to restrict SPC protection On 28 May, 2018, the European Commission published its proposal to amend Regulation (EC) No 469/2009 concerning supplementary protection certificate for medicinal products. Urged by the European Parliament, the Commission introduces a so-called manufacturing exemption for export purposes, also known as...
Unitary SPCs in Europe after all?
By Niklas Mattsson | Posted on February 3, 2016
As readers of this blog know, we at Awapatent are actively following the exciting developments in the creation of a unitary patent system in Europe. It will be possible to obtain European patents with unitary effect in 25 countries, and we’ll have a new Unified Patent Court (UPC) for centralized patent disputes. We look forward...
Tags: EU Commission, SPC, Supplementary Protection Certificates
Recent contributors
Partner, European Patent Attorney
Senior Associate, Attorney at Law
Partner, Attorney at Law, Group Vice President
Partner, Attorney at Law, Business Area Manager
Senior Counsel, European Patent Attorney
